Crowdonomics
WatchlistPortfolio
DataBiologics

Reg CF · SAFE · Oct 2024

ClosedReached targetReg CFSAFE
via WeFunderView campaign
Raised
$259.1K / $1.2M max
21% of ceiling · target hit day 3
Investors
61
$4.2K avg
Valuation cap
$10M
cap, not an agreed valuation

Raised over time

Cumulative raisedInvestors
$259K$130K$0
61310
Oct 15, 2024 · openedApr 30, 2025 · last reading
Target ($50K) hit — Oct 18, 2024, day 3Deadline Apr 30, 2025 — 0 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$59K
−$334K
FY2022
$275K
−$485K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$58,512
$275,446
Cost of goods sold
$14,852
$0
Gross margin
75%
100%
Net income
-$334,463
-$484,507
Taxes paid
$0
$0
Balance sheet
Cash
$9,596
$179,344
Accounts receivable
$0
$0
Total assets
$260,490
$403,367
Short-term debt
$0
$106
Long-term debt
$130,000
$717,278
Total liabilities
$130,000
$717,384
Other
Headcount
—
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Valuation cap$10M ($9M early bird)

Perks

First $250K of investments will be in a safe with a $9M valuation cap and 10% discountfirst $250K

Offering details

Target$50,000
Max$1,235,000
Min investment$100
OpenedOct 15, 2024
DeadlineApr 30, 2025
ClosedApr 30, 2025
Days active197

Links & provenance

Campaign pageSEC filing
Source: Manual
0001670254-24-000960

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.